All UK & Rest of Europe articles
-
NewsDamaged but not defeated: Bacteria use nano-spearguns to retaliate against attacks
Scientists used state-of-the-art microscopy technology to mimic a nano-speargun, the type VII secretion system, used as a bacterial pinpoint counterattack tactic in response to cell envelope damage against rival bacteria.
-
NewsAdaptation to extreme conditions: thermal water biofilm studies could help understand ancient ecosystems
Researchers have discovered unique bacterial communities in thermal waters that may help unravel the development of stromatolites, one of Earth’s oldest rock formations.
-
NewsLonger breastfeeding linked to blood-pressure lowering effects of certain infant gut bacteria
An observational study has found that infants who had more diverse bacteria in their gut had lower childhood blood pressure, and this protective association was stronger if they were breastfed for at least six months.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsAMI member Christopher Stewart named as laureate in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Professor Christopher Stewart of Newcastle University has been named as one of three 2025 laureates in the eighth Blavatnik Awards for Young Scientists in the UK.
-
NewsCentauri Therapeutics selects first clinical candidate for immunotherapeutic treatment of Gram-negative bacterial infections
Centauri Therapeutics Limited has announced the selection of its first clinical candidate in the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial infections in the lung.
-
NewsStudy uncovers the core principles of low-resistance antibiotics
Researchers have demonstrated that a dual-target approach, combining membrane disruption with an additional critical cellular pathway, significantly prevents the development of resistance in bacteria.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
CareersMy PhD Experience: Collaborations between academia and industry in the microbial bioremediation of marine oil pollution
Jake A Smallbone reveals how a industry collaboration as part of his PhD led to work on a real world oil spill to uncover the fascinating ways that bacterial communities respond to pollution and can be deployed as biomarkers and in bioremediation.
-
NewsCambridge initiative to address risks of future engineered pandemics
Management strategies are initiated by University of Cambridge to address the challenges and preventive measures required in response to a potential engineered pandemic threat in the future.
-
NewsToxic chemical pollutants detected in lichens and mosses in the Irati forest
Scientists used a species of lichen (Parmelia sulcata) and a species of moss (Hypnum cupressiforme) from Irati Forest as sentinels or biomonitors to determine the organic pollution in the atmosphere.
-
NewsReactive nitrogen species dominance is key in the fight against antimicrobial resistance
The balance between two types of molecules – reactive nitrogen species (RNS) and reactive oxygen species (ROS) – plays a crucial role in tackling drug-resistant bacteria, according to a new study.
-
NewsInterventions could eliminate transmission of hepatitis B from mothers to babies in Africa
Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps needed to combat the vertical transmission of chronic hepatitis B virus (HBV) in Africa. Source: Solasly A baby in the womb of its mother being held by its mother and ...
-
NewsFlu vaccine offers moderate protection against strains dominant in most European countries in 2024/2025
According to interim analysis of influenza vaccine effectiveness for the 2024/2025 season in Europe, the vaccine offered moderate protection against dominant influenza A strains, and strong protection against influenza B.
-
NewsNewly launched Enodia Therapeutics is a biotech company with a new approach for targeted protein degradation
Argobio and the Institut Pasteur have announced the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections.
-
NewsDiscovery of a common ‘weapon’ used by disease-causing fungi could help engineer more resilient food crops
The discovery of a powerful “weapon” used by many disease-causing fungi to infect and destroy major food crop staples, such as rice and corn, could offer new strategies to bolster global food security
-
NewsA new test will make it possible to detect the parasite responsible for trichomoniasis more quickly and inexpensively
A sensitive, cheap and rapid test is developed to detect the parasite, Trichomonas vaginalis, which causes one of the world’s most common sexually transmitted infections, using an innovative approach that targets highly specific molecules with short nucleic acid sequences.
-
NewsWorld first clinical trial will study specialized ‘poop pills’ to improve treatment of advanced pancreatic cancer
A world-pioneering fecal microbiota transplantation pill will undergo a clinical trial, aiming to improve immune responses by remodifying the gut microbiome in patients with advance pancreatic cancer.
-
NewsA blueprint for making cereal crops more resistant to fungal disease
Researchers have uncovered the structural interactions between a type of barley immune receptor that helps the crop to fight against devastating fungal disease, powdery mildew and other plant pathogens.
-
NewsGastric bacteria ‘leaking across stomach lining’ could indicate risk of gastric cancer
A new discovery in the roles of gastric microbiota bacteria and Helicobacter pylori across the stomach lining during pre-cancerous stage of gastric cancer development could be the missing link for engineering future therapeutic intervention.